Unitaid, Part of the World Health Organization Funding Ivermectin Research Targeting COVID-19 led by British Expert

Unitaid, Part of the World Health Organization Funding Ivermectin Research Targeting COVID-19 led by British Expert

Just recently ,Dr. Andrew Hill, Sr. Visiting Fellow, Department of Pharmacology, University of Liverpool, shared on YouTube an interim, meta-analysis revealing the significant potential of Ivermectin as a treatment targeting SARS-CoV-2, the virus behind COVID-19. Dr. Hill’s current meta-analysis study is funded ongoing by Unitaid, part of the World Health Organization’s ACT Accelerator initiative to improve access to COVID-19 treatment and diagnostics. The researcher’s meta-analysis, while still ongoing, points toward significant promise for Ivermectin, as a low cost, widely available therapy potentially useful targeting COVID-19. What are his findings thus far? Well, this meta-analysis involving 11 randomized controlled trials associated with 1,452 patients evidences A) Faster time to viral clearance; B) Shorter duration of hospitalization; C) 43% higher rates of clinical recovery; and D) 83% improvement in survival rates. What’s next? A few big Ivermectin studies will produce results within weeks. Then, he’ll approach the 3,000 patient number: that was the figure initially used as a basis for the Remdesivir authorization.

TrialSite offers a link to the YouTube page Ivermectin...

Note:  If you need assistance with your subscription or would like to discuss a corporate subscription for more than 10 employees please contact us or use the chat (bottom right).

Personal
$5 / Month
Individuals at home that are reading our content for personal health care or other non-professional reasons.
Like a Starbucks a month
Personal - Single Payment
$50 for 1 Year
Individuals - reading for personal reasons who prefer to pay for one year in advance with no recurring billing.
18% discount to monthly
Professional
$12 / Month
Professionals from the healthcare industry who are subscribing on behalf of their company for work reasons.
Way better than coffee